Policy & News
Five Chinese drugmakers licensed to make generic versions of Pfizer's new Crown oral drug
2023-01-09
On 18 March Beijing time, the official website of Geneva Medicines PatentPool (MPP) announced that it had signed agreements with 35 companies, which were allowed to produce generic versions of nirmatrelvir, one of the components of Pfizer's new crown jewel, Paxlovid, as APIs or preparations.
View More
2023-01-09
Recently, two new inactivated coronavirus vaccines (Omicron variant, hereinafter referred to as "O-strain") developed by Sinopharm's China Biologicals Beijing Bioproducts Research Institute and Wuhan Bioproducts Research Institute have been approved by the Research Ethics Committee of the University of Hong Kong and Hong Kong Island West Hospital of the Hospital Authority, as well as by the Clinical Trial Approval from the Pharmacy and Poisons Board of Hong Kong, and have been formally authorised to carry out a sequential immunisation clinical study of the new coronavirus vaccines in Hong Kong.
View More
Sinopharm, Kexing Omicron variant of new crown vaccine approved for clinical use in China
2023-01-09
On 26 April, Sinopharm China Biotechnology Company Limited and Kexing Holdings Biotechnology Company Limited announced that their Omicron variant strain of inactivated neocoronavirus vaccine had been granted clinical approval by China's State Drug Administration respectively.
View More
Hand in hand to build the dream of Kangrun
2023-01-09
On the morning of 22nd July, 2022, the new staff development training with the theme of "Youthful Excitement, Creating Brilliance, Pursuing Excellence and Embodying Values" kicked off in Jintan, Changzhou. The new staff development was carried out in two batches, with a total of more than 130 employees participating in the training. The training aims to enhance communication and understanding between employees, strengthen team cohesion and centripetal force, and create a unity and mutual help, positive and upward corporate culture atmosphere.
View More
Communication, Collaboration, Win-Win - Cross-sectoral Communication and Collaboration
2023-01-09
Departmental wall is an invisible "wall" that hinders the transmission of information and exchange of work between departments and employees within the enterprise. In order to strengthen the effective communication and collaboration between departments, so as to improve work efficiency and ensure the smooth progress of the work. 5 August 2022, the company invited Mr. Zhou Wenbin to give the management personnel above the head of the team the theme of "cross-departmental communication and collaboration" training.
View More
2023-01-08
Is the perception of influenza still stuck in 2020, thinking that influenza is still at a low pandemic level? In fact, this is not the case. Influenza has gradually regained its "vitality" and returned to the seasonal influenza epidemic status before the new Crown Pneumonia outbreak. What is the situation of influenza epidemic this year? Let's look at the "2022 Seasonal Influenza Prevention and Control Strategies Symposium" hosted by the Chinese Preventive Medical Association, which ended on 6.11, and the interpretation of experts from the CDC.
View More
